AWAK Transforms into Vivance, Unveiling a New Brand Identity

FacebookFacebookTwitterTwitterEmailEmailLinkedInLinkedInWhatsAppWhatsAppMessengerMessengerFlipboardFlipboardGmailGmailTelegramTelegramShareShare

SINGAPORE, Oct. 9, 2024 /PRNewswire/ — AWAK Technologies, a pioneer in innovative kidney care is excited to announce its rebranding to Vivance. The name, derived from ‘viva’ and ‘advance’, embodies vitality and progress – hallmarks of the company’s commitment to revolutionizing kidney health.

AWAK Technologies was founded with a groundbreaking idea: the development of a wearable dialysis device, Automated Wearable Artificial Kidney (AWAK). As the company continues its mission to transform kidney care, the portfolio has been expanded with products that aim to enhance patient outcomes and quality of life. To reflect this evolution and commitment to innovation, it has rebranded to Vivance – a name that captures its dynamic and forward-thinking approach in managing kidney health.

Suresha Venkataraya, CEO of Vivance, said, “This rebrand reflects how far we’ve come, and where we’re heading. Building on the foundation of our wearable dialysis device, we’ve made significant strides by expanding our portfolio to include cost-effective home modalities and complementary digital offerings. This rebrand reinforces our ultimate mission of treating patients in the comfort of their homes.”

Abel Ang, Chairman of Vivance, added, “We are excited to introduce Vivance to the world. Building on two breakthrough device designations from the FDA, our rebranding accelerates our mission to revolutionize healthcare. This exciting new chapter for the company will see us take patient-centric dialysis from a dream into reality.”

Looking Ahead

As Vivance, the company will continue to refine its brand strategy, product positioning, and approach to market entry, ensuring a strong and strategic alignment with industry needs. The wearable dialysis device is progressing through clinical trials, while additional innovations, such as point-of-care PD fluid generation system, remote monitoring tools and AI prediction models, are in advanced stages of research and development. These products are poised to enter their clinical phases in the near future, reinforcing Vivance’s mission to drive meaningful disruption in the kidney care sector.

Media Contact:

Priyanka Arya
Senior Marketing Manager
+65 6950 5011
priyanka.arya@awak.com 

About Vivance

Vivance, formerly AWAK Technologies, is a pioneering, patient-centric medical technology company with a mission to enhance the lives of people with kidney disease and their caregivers by providing solutions to deliver better outcomes and improve their quality of life.

Headquartered in Singapore with offices in Los Angeles, United States and Bengaluru, India, the company is dedicated to the research, development and marketing of novel technologies in kidney care. 

View original content to download multimedia:https://www.prnewswire.com/news-releases/awak-transforms-into-vivance-unveiling-a-new-brand-identity-302269579.html

SOURCE Vivance Pte Ltd

Staff

Recent Posts

WellPact Achieves HITRUST i1 Certification to Manage Data Protection and Mitigate Cybersecurity Threats

HITRUST certification validates WellPact is operating leading security practices to protect sensitive information. ROARING SPRING,…

10 hours ago

Advanced Biological Research Group to Study Effects of mRNA on Women’s Reproduction

JACKSONVILLE, Fla., June 5, 2025 /PRNewswire/ -- Advanced Biological Research Group (ABRG), a 501c3, has…

10 hours ago

ImageTrend Ensures Continuity of EMS Data Reporting for Michigan Agencies

EAGAN, Minn., June 5, 2025 /PRNewswire/ -- The Michigan Department of Health and Human Services (MDHHS)…

10 hours ago

Archetype Announces Investment with Enrollment Management Services

PHILADELPHIA, June 5, 2025 /PRNewswire/ -- Archetype, a growth equity investment firm, has announced an…

10 hours ago

TALON and HealthAxis Announce Strategic Partnership to Exceed Member Expectations

PORTSMOUTH, N.H. and TAMPA, Fla., June 5, 2025 /PRNewswire/ -- TALON, the nation's leader in…

10 hours ago

Private Astronaut Mission Includes Research to Open Space to Astronauts With Diabetes and Enable Early Cancer Detection

Axiom Mission 4 partners with ISS National Lab to conduct the most research to date…

10 hours ago